Prices
ATS Login
Learn more
Home
Tables by benefits - sickness/health care function
methods, notes and classification
Tables by benefits - sickness/health care function
methods, notes and classification
Methods
Variables
Download
ESSPROS-expenditure
00
Social protection benefits
01
Non means-tested benefits
02
Means-tested benefits
03
Cash benefits
04
Cash benefits (non means-tested)
05
Cash benefits (means-tested)
06
Periodic cash benefits
07
Periodic cash benefits (non means-tested)
08
Periodic cash benefits (means-tested)
09
Paid sick leave benefit
0a
Paid sick leave benefit (non means-tested)
0b
Paid sick leave benefit (means-tested)
0c
Other periodic cash benefits
0d
Other periodic cash benefits (non means-tested)
0e
Other periodic cash benefits (means-tested)
0f
Lump sum cash benefits
0g
Lump sum cash benefits (non means-tested)
0h
Lump sum cash benefits (means-tested)
0i
Other lump sum cash benefits
0j
Other lump sum cash benefits (non means-tested)
0k
Other lump sum cash benefits (means-tested)
0l
Benefits in kind
0m
Benefits in kind (non means-tested)
0n
Benefits in kind (means-tested)
0o
In-patient care
0p
In-patient care (non means-tested)
0q
In-patient care (means-tested)
0r
In-patient care direct provision
0s
In-patient care direct provision (non means-tested)
0t
In-patient care direct provision (means-tested)
0u
In-patient care reimbursment
0v
In-patient care remboursment (non means-tested)
0w
In-patient care remboursment (means-tested)
0x
Out-patient care
0y
Out-patient care (non means-tested)
0z
Out-patient care (means-tested)
10
Out-patient care direct provision of pharmaceutical products
11
Out-patient care direct provision of pharmaceitical products (non means-tested)
12
Out-patient care direct provision of pharm. products (means-tested)
13
Out-patient care other direct provision
14
Out-patient care other direct provision (non means-tested)
15
Out-patient care other direct provision (means-tested)
16
Out-patient care reimbursment of pharmaceutical products
17
Out-patient care rembursment of pharmaceutical products (non means-tested)
18
Out-patient care rembursment of pharmaceutical products (means-tested)
19
Out-patient care other reimbursment
1a
Out-patient care other rembursment (non means-tested)
1b
Out-patient care other rembursment (means-tested)
1c
Other benefits in kind
1d
Other benefits in kind (non means-tested)
1e
Other benefits in kind (means-tested)
ESSPROS-category of schemes
0
All schemes
Unit of measure
0
Million euro
1
Euro per inhabitant (at constant 2010 prices)
2
Million units of national currency
3
Million purchasing power standards (PPS)
4
Purchasing power standard (PPS) per inhabitant
5
Percentage of gross domestic product (GDP)
Geopolitical entity (reporting)
00
European Union - 27 countries (from 2020)
01
European Union - 28 countries (2013-2020)
02
European Union - 27 countries (2007-2013)
03
European Union - 15 countries (1995-2004)
04
Euro area – 20 countries (from 2023)
05
Euro area - 19 countries (2015-2022)
06
Euro area - 18 countries (2014)
07
Euro area - 12 countries (2001-2006)
08
Belgium
09
Bulgaria
0a
Czechia
0b
Denmark
0c
Germany
0d
Estonia
0e
Ireland
0f
Greece
0g
Spain
0h
France
0i
Croatia
0j
Italy
0k
Cyprus
0l
Latvia
0m
Lithuania
0n
Luxembourg
0o
Hungary
0p
Malta
0q
Netherlands
0r
Austria
0s
Poland
0t
Portugal
0u
Romania
0v
Slovenia
0w
Slovakia
0x
Finland
0y
Sweden
0z
European Economic Area (EEA18-1995, EEA28-2004, EEA30-2007, EEA31-2013, EEA30-2020)
10
Iceland
11
Norway
12
Switzerland
13
United Kingdom
14
Bosnia and Herzegovina
15
Montenegro
16
North Macedonia
17
Albania
18
Serbia
19
Türkiye